Advertisement

Topics

StemImmune signs deal with Accurexa for cancer immunotherapy development

05:41 EDT 18 Oct 2016 | SmartBrief

StemImmune and Accurexa will collaborate on the development of a stem cell-mediated cancer immunotherapy using StemImmune's i -More

Original Article: StemImmune signs deal with Accurexa for cancer immunotherapy development

NEXT ARTICLE

More From BioPortfolio on "StemImmune signs deal with Accurexa for cancer immunotherapy development"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...